Questions about Adderall XR.
Biron
Pierre
P
Mintzes
Barbara
B
Lexchin
Joel
J
D000662:Amphetamines / Q000009:adverse effects*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002170:Canada; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D007880:Legislation, Drug
C090411:Adderall; D000662:Amphetamines; D000697:Central Nervous System Stimulants